Small Giants Summit 2018: Authenticity The #SGCSummit2017 in Detroit this past May was an incredible experience: inspiring stories and best practices were shared, meaningful relationships were built, and Detroit’s rich and exciting reinvention was explored. Detroit’s beautiful Garden Theater offered the ideal setting for the magic of the #SGCSummit2017 to unfold [..]
2018 Forbes America’s Best Small Giants Nominations You’re in the right place! Tell us more… Forbes is embarking on its third annual quest to find and recognize America’s Best Small Companies in partnership with the Small Giants Community. Help us recognize the companies you love, so we can show them some [..]
The 25th Annual Gathering of Games: All-Star Reunion World’s Largest Open-Book Management Conference Dallas, TX | September 6-8, 2017 The Annual Gathering of Games, presented by the Great Game of Business, is the only conference where the open-book management community comes together from around the world to learn, share, and [..]
7th Annual Congress On Clinical Microbiology (8 Plenary forums, 2 days, 1 event) September 25-26, 2017 Chicago, Illinois, USA Theme: Advances in Infectious Diseases and future trends in Clinical Microbiology About Conference After the success of Clinical Microbiology 2012- 2015 , Conferenceseries is glad to announce 7th Annual conference on Clinical Microbiology [..]
New Hydrogel-Based Capsules: Ingestible And Slowly Drug releasing Material By: Helen Knight | MIT News correspondent Around half of all medications for chronic diseases are not taken as prescribed, costing the U.S. health care system more than $100 billion in avoidable hospital stays each year. This noncompliance is even more significant [..]
Puma’s NERLYNX™ (Neratinib) An Extended Adjuvant Treatment For Breast Cancer: Approved by FDA By: Puma Biotechnology News Puma Biotechnology, Inc. (Nasdaq: PBYI) announced that the U.S. Food and Drug Administration (FDA) has approved NERLYNX™ (neratinib), formerly known as PB272, a once-daily oral tyrosine kinase inhibitor for the extended adjuvant treatment of [..]
FDA Approves Gilead’s Vosevi™ for Re-Treatment of Hepatitis C By: Gilead Sciences News Gilead Sciences, Inc.(NASDAQ: GILD) announced that the U.S. Food and Drug Administration (FDA) has approved Vosevi™ (sofosbuvir 400 mg/velpatasvir 100 mg/voxilaprevir 100 mg) tablets, a single-tablet regimen for the re-treatment of chronic hepatitis C virus (HCV) infection in adults [..]
This Novel Molecular Switch Could Be Useful To Treat Parkinson’s, Arthritis and Other Diseases By : Kristin Samuelson | NW News A groundbreaking advancement in materials from Northwestern University could potentially help patients requiring stem cell therapies for spinal cord injuries, stroke, Parkinson’s disease, Alzheimer’s disease, arthritic joints or any other [..]
Probiotic Beer : That Improves Gut Health And Boosts Immunity By: NUS News Beer lovers may soon have a gut-friendly drink to raise a toast to, thanks to the creation of a novel probiotic sour beer by a team of researchers from the National University of Singapore (NUS). This new specialty [..]
First Battery-Free Cellphone By: Jennifer Langston | UW News University of Washington researchers have invented a cellphone that requires no batteries — a major leap forward in moving beyond chargers, cords and dying phones. Instead, the phone harvests the few microwatts of power it requires from either ambient radio signals or light. [..]
FDA Recommended Approval For Gene-Altering Immunocellular Personalized Therapy Against Cancer By: Novartis News Novartis announced today that the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) unanimously (10-0) recommended approval of CTL019 (tisagenlecleucel), an investigational chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of relapsed or refractory (r/r) [..]
FDA Approves Endari™, the First Treatment for Pediatric Sickle Cell Disease By: Emmaus Life Sciences Inc. News Emmaus Life Sciences Inc. announced that the U.S. Food and Drug Administration (FDA) approved EndariTM (L-glutamine oral powder) to reduce the severe complications of sickle cell disease (SCD) in adult and pediatric patients age 5 [..]
A New Mechanism for Genome Regulation By: Sarah Yang| Berkeley Lab News The same mechanisms that quickly separate mixtures of oil and water are at play when controlling the organization in an unusual part of our DNA called heterochromatin, according to a new study by researchers at the Department of [..]
A Microscopic Guillotine To Study Single-Cell Wound Repair July 2, 2017 By: Taylor Kubota | Stanford News While doing research at the Woods Hole Marine Biological Laboratory in Massachusetts, Sindy Tang learned of a remarkable organism: Stentor coeruleus. It’s a single-celled, free-living freshwater organism, shaped like a trumpet and big enough to see with [..]
A Novel Eco-friendly Method To Extract The Copper By: Denis Paiste | Materials Processing Center Julye 2, 2017 MIT researchers have identified the proper temperature and chemical mixture to selectively separate pure copper and other metallic trace elements from sulfur-based minerals using molten electrolysis. This one-step, environmentally friendly process simplifies [..]
FDA Approved HAEGARDA® First and Only Treatment for Angioedema: A Rare Hereditary Disease By: CSL Behring News HAEGARDA has been shown to reduce HAE attacks by 95 percent (median) in patients with a life-threatening, rare genetic disorder Use of rescue medication was reduced by greater than 99 percent1 Subcutaneous administration builds [..]
A New Broad-Spectrum Diagnostic Weapon Against Cancer By : Lindsay Brownell | Wyss Institute News Cancerous tumors are formidable enemies, recruiting blood vessels to aid their voracious growth, damaging nearby tissues, and deploying numerous strategies to evade the body’s defense systems. But even more malicious are the circulating tumor cells (CTCs) that [..]
Copyright © 2024 | WordPress Theme by MH Themes